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 Sirtuins are a class of nicotinamide adenine dinucleotides (NAD)-dependent histone 
deacetylases (HDACs) found in all three domains of life.  Acetylation-deacetylation of histones 
lysine residues is an accepted paradigm for gene regulation in eukaryotes.  In recent years, 
proteonomic studies revealed that many cellular proteins are acetylated and are regulated by post 
translational modifications.  Although initially, sirtuins gained notoriety when Sir2 yeast was 
discovered to increase life span under calorie restriction, current research suggests that sirtuins 
are involved in a myriad of other cellular functions.  The discovery of Sirt5’s, a type III 
mammalian sirtuin,novel desuccinylase/demalonylase activity opened up new possibilities of 
cellular protein regulation.  Two conserved active site residues, Tyr and Arg, are believed to be 
responsible for Sirt5’s desuccinylase/demalonylase activity.  The physiological importance of 
lysine succinylation and malonylation is strengthened by proteonomic studies that have 
identified succinylated and malonylated proteins.  Many of those proteins are involved in 
metabolism and gene regulation suggesting that Sirt5 is important.   
 Our aim was to verify the importance of the two conserved residues in type III sirtuins 
and investigate the physiological significance of these new post translational modifications in a 
bacterial model.  We investigated the activity of two sirtuins, E. coli CobB, bears the two active 
site residues, and Plasmodium falciparum Sir2A (PfSir2A), a type III sirtuin missing the 
conserved residues, and found that only CobB has desuccinylase activity while PfSir2A prefers 
to remove long fatty acyl chains.  We followed up on the physiological relevance of lysine 
succinylation by screening for CobB substrates in E. coli and found that CobB can regulate 
RcsB’s DNA binding capability by lysine desuccinylation.  We also investigated CobB’s 
influence on metabolism in different nutrient conditions and found that desuccinylation was not 
important in acetate, succinate and propionate supplemented nutrients.   
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CHAPTER 1: BRIEF OVERVIEW OF MAMMALIAN SIRTUINS AND 
THE FUNCTION OF DEACETYLATION AND ACETYLATION IN 
BACTERIAL CELLS 
ABSTRACT 
 
Sirtuins are nicotinamide adenine dinucleotide (NAD)-dependent deacetylases. When it 
was discovered that Sir2 in yeast can promote longevity in conjunction with calorie restriction, 
sirtuins garnered significant attention.  Since then, the study of sirtuins have revealed a myriad of 
functions spanning from metabolism, cancer, stress and chromatin regulation in addition to 
healthspan.  Mammals have 7 sirtuins, Sirt1-7, that were designated with deacetylase activity.  
Lysine deacetylation and acetylation has been well studied on histones and non-histones proteins 
in mammalian cells.  However, in bacteria the purpose of this lysine acetylation and 
deacetylation paradigm is still largely unknown due to lack of research.  Here we will review the 
function of lysine acetylation in bacteria and how sirtuins are involved.   
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INTRODUCTION 
Sirtuins are a class of histone deacetylases (HDACs) that needs nicotinamide adenine 
dinucleotide (NAD) as a co-substrate to function.  They are found in all three domains of life, 
bacteria, archaea and eukaryote.  The most complex organism can have up to 7 sirtuins, as seen 
in humans, while bacteria such as S. enterica and E. coli have only one[1].   A phylogenetic 
study of sirtuins by sequence alignment classified them into 5 types: I, II, III, IV and U.  A 
popular model for the evolution of of sirtuins in eukaryotes is that the first eukaryote received its 
sirtuins from the engulfment of an α-proteobacterium by an archaean which supplemented a type 
II and U and type III sirtuins, respectively.  Since type I and IV have the greatest sequence 
similarity to type U, it is most likely that type I and IV sirtuins evolved from type U (Fig.1) [2].  
 Mammals have 7 sirtuins (Sirt1-Sirt7) which encompasses the four major types of 
sirtuins (I-IV) [1].  Sirt1 to Sirt3 are type I sirtuins, Sirt4 belongs to type II sirtuins, Sirt5 is a 
type III sirtuin and Sirt6 and Sirt7 are type IV sirtuins.  Sirt1-7 are localized differently in the 
cell and expression levels are tissue dependent [3].  Sirt1, Sirt6 and Sirt7 are localized primarily 
in the nucleus, Sirt2 is mainly a cytosolic enzyme and Sirt3, Sirt4 and Sirt5 are localized in the 
mitochondria[4]. The type I sirtuins have robust deacetylation activity, while type II to type IV 
have very weak to no deacetylase activity [4].  Although reports suggested that some of these 
sirtuins could be ADP-ribosyltransferases [5], our data and that from Denu and coworkers 
suggest that the ADP-ribosyltransferase activity of sirtuins is very weak and unlikely to be 
physiologically relevant [6, 7].   
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Figure 1.  Evolution of sirtuins.  There are 5 types of sirtuins, I-IV and U, and each type has a characteristic 
function. A popular model for the evolution of sirtuins in the first eukaryote is that the parent archaean, 
which carried type III already, engulfed a protobacterium that carried type II and type U sirtuins. Eventually 
type I and IV sirtuins evolved from type U sirtuins.   Mammals have 7 sirtuins, Sirt1-7.  Sirt1-3 are type I 
sirtuins that each exhibits robust deacetylase activity.  Sirt4 is a type II sirtuin which exhibits a weak 
deacetylation activity and may function as a defatty-acylase.  The exact functions and enzymatic mechanism 
are still unknown.  Sirt5 is a type III sirtuin that also has weak deacetylase activity, but has recently been 
found to be a strong desuccinylase/demalonylase.  Sirt6 has made some strides recently as a deacetylase, 
however, its deacetylase activity is relatively weak when compared to its demyristoylation activity.  While 
Sirt7 is still a mystery, we can hypothesize that since it is in the same class as Sirt6, it is most likely a long 
chain defatty-acylase.  Figure adapted from [8] .   
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THE EFFECT OF (PTMS) ACETYLATION AND DEACETYLATION ON LYSINE RESIDUES IN 
BACTERIA 
 
Lysine acetylation of histones established the importance of gene regulation by post-
translational modifications, but later proteomics studies discovered that non-histone proteins 
were also lysine acetylated suggesting that lysine acetylation may be involved in many 
eukaryotic cell processes[9, 10].   The two separate proteomics studies found hundreds of 
acetylated lysine residues on as many as 91 E. coli proteins[9, 10].  While the proteins identified 
in both studies contained similar proteins only the lysine residues listed in Table 1 were 
identified in both studies.  The majority of the modified proteins were metabolic enzymes and 
translation regulators[9, 10].  The array of proteins found to be acetylated in E. coli indicates that 
this modification is a highly abundant and evolutionarily conserved post translational 
modification found in diverse functions of life[9, 10].  
Many  bacterial proteins have confirmed functions regulated by acetylation.  Acetyl-
coenzyme A synthetase (ACS), CheY, and RcsB have been identified and experimentally 
determined to be regulated by the acetylation/deacetylation of targeted lysine residues[11, 12].  
ACS can catalyze the production of acetyl-CoA from acetate and coenzyme A in an ATP driven 
reaction[11].  The acetylation of a highly conserved lysine residue (lys609) blocks the 
adenylation of acetate, and hence the production of acetyl-CoA[11].  This example highlights the 
importance of acetylation/deacetylation in bacterials cells because acetyl-CoA is at the core of 
central metabolism.  Interestingly enough activated ACS can acetylate CheY, a chemotaxis 
regulator[12].  It has been found that upon acetylation of a lysine residue cluster, CheY loses its 
ability to bind CheA, CheZ and FliM and hence its chemotactic abilities[12].  This was later 
found to be part of a slow mode of regulation dictated by the metabolic state of the cells[12].  A 
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fast mode of regulation is mediated by phosphorylation of CheY, with CheA as the phosphor 
donor[12].  While CheY can be auto-acetylated with acetyl-coA as a donor, Δacs mutants exhibit 
defective chemotactic responses[12]. Thus, this rules out any significant effect that auto-
acetylation may have in regulation of CheY and at the same time supports that the acetylation of 
CheY by ACS may likely be apart of an acetylation cascade[13].    
Table 1.  Lysine-acetylated proteins identified from two independent studies.  Only 8 of the proteins had the 
same acetylated peptides identified in both experiments.  Extracted from [9, 10].   
 
Another recent paper studying acetylation discovered that gene regulation in bacteria may 
also be regulated by acetylation/deacetylation[14]. The paper identified that RcsB, a transcription 
regulator that mediates many cellular processes such as cell division, motility, osmotic responses 
and capsule biosynthesis can be deacetylated at lys140 by CobB[14].  Deacetylation of RcsB 
activates its ability to bind DNA, specifically the binding of flhCD operator sequence[14].  This 
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was the first paper to demonstrate that like eukarotyes, bacterial transcription is also regulated by 
acetylation/deactylation[14]. The involvement of  sirtuins in the deacetylation of lysines have 
demonstrated the importance of acetylation  in the regulation of metabolism and gene regulation 
in mammals.  
 
Figure 2.  Deacylation of lysine residues catalyzed by CobB.   
There are two main enzymes that have been identified as the regulators of 
acetylation/deacetylation paradigm in bacterial cells.  PAT, protein acetyl transferase, in most 
cases acetylates lysine residues while, CobB, an NAD dependent sirtuin catalyzes the 
deacetylation of lysines[11].  CobB is the only known bacterial sirtuin in S. enterica and E. coli 
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and it is a type III sirtuin similar to that of Sirt5 found in humans.  We determined 
experimentally that CobB is a multifunctional enzyme that carries many activities (figure 2).  
Through an in vitro screen with various lysine acylated H3K9WW peptides, we determined that 
CobB has a strong activity for acetylated, succinylated and myristoylated lysine residues.  
 In Chapter 2, we will further discuss CobB’s enzymatic activity and how those functions 
help regulate cellular functions.  The identification of succinylated lysine residues across species 
in a proteomics study suggests that succinylation/desucccinylation may be another paradigm that 
is important for cellular regulation in eukaryotes as well as prokaryotes.   Since CobB is 
multifunctional, it is important to investigate the singular and combination effect that its 
activities may have downstream on its substrates and processes.  This new discovery also shows 
us how intricate the web of posttranslational modifications is in cells.  In the following chapters 
we will investigate two type III proteins that both exhibit novel sirtuin activities and the role 
these sirtuins play in cellular function.   
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CHAPTER 2: COBB IS A PROMISCUOUS SIRTUIN 
ABSTRACT 
Sirtuins are traditionally known as nicotinamide adenine dinucleotide (NAD) –dependent 
deacetylases and they exist in all three domains of life.  Many bacterial sirtuins such as CobB in 
E. coli and S. enterica have the greatest sequence homology to Sirt5, a type III sirtuin. Recent 
discovery of Sirt5’s desuccinylase/demalonylase activity has opened up possibilities of a new 
paradigm.   Two residues, Arg and Tyr, found in most type III sirtuins are responsible for Sirt5’s 
lysine malonyl/succinyl activity.  These observations prompted us to examine whether all type 
III bacterial sirtuins, specifically E. coli CobB, can catalyze demalonylation or desuccinylation. 
Previously CobB has been reported to regulate metabolism in S. enterica when it upregulates the 
activity of acetyl-CoA synthetase (ACS) by lysine deacetylation. CobB has also demonstrated 
gene regulatory capabilities with E. coli RcsB, a transcription factor responsible for a complex 
signal transduction network.  We have found that E. coli. CobB is a multifunctional enzyme with 
robust deacetylase as well as desuccinylase activity. We investigated CobB’s desuccinylation 
activity in regards to metabolism and gene regulation and have found that while there appears to 
be no significant affect to metabolism, desuccinylation is important for the DNA-binding 
capabilities of RcsB.  Our investigation shows that it is desuccinylation of RcsB rather than 
deacetylation that increases DNA binding.   
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INTRODUCTION 
Sirtuins are a class of HDACs known as nicotinamide adenine dinucleotide (NAD)-
dependent deacetylases [1]. About half of the mammalian sirtuins have very weak or no 
deacetylase activity in vitro [15]. Recently, we discovered that human Sirt5, a type III 
mitochondrial sirtuin that has weak deacetylase activity, can catalyze the hydrolysis of malonyl 
and succinyl lysine peptides much more efficiently than the hydrolysis of acetyl lysine peptides 
[16]. Furthermore, mammalian proteins were found to contain malonyl and succinyl lysine 
modifications [16]. The recognition of malonyl and succinyl groups by Sirt5 is determined by the 
presence of an arginine and tyrosine residue in the active site [16]. The arginine and tyrosine 
residues are conserved in most type III sirtuins, including E. coli CobB. Here we report that E. 
coli CobB, similar to Sirt5 can catalyze the hydrolysis of succinyl lysine efficiently. However, 
different from Sirt5, the deacetylase activity of CobB is also very efficient, suggesting that E. 
coli CobB is a multifunctional sirtuin. Furthermore, we found that succinyl lysine is also present 
in E. coli proteins. More succinyl peptides were identified from a CobB deficient strain, 
suggesting that CobB controls the succinylation level in E. coli. Given that succinylated proteins 
are involved in a myriad of functions in the cell, from DNA regulation to metabolism, we 
investigate the relevance of  lysine succinylation in E. coli.   
Metabolism is required for the survival and proper function of all living cells. 
Posttranslational modifications of metabolic enzymes have been increasingly recognized as 
important means of regulating metabolism [17]. Recent proteomic studies revealed that many 
metabolic enzymes are acetylated on lysine residues and acetylation-deacetylation regulates the 
activity of the metabolic enzymes in response to nutrient conditions, in both mammals and 
bacteria [18, 19] .  We wondered if the same is true about succinylation-desuccinylation and 
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studied the relevance of CobB and R95M, a mutant of CobB deficient in desuccinylase activity, 
in a ΔcobB E. coli strain under different nutrient conditions.  While we identified several 
succinylated metabolic proteins, we could not establish the physiological relevance of this novel 
PTM.   
Post-translational modifications on histones has been a widely accepted concept that is 
important in gene regulation [20, 21].  The model of histone acetylation-deacetylation is 
especially important for the DNA transcription.  While this model has been established in many 
Eukaryotic organisms, in bacteria it is still a fairly new concept.  Recently, it was reported that 
RcsB, a transcription factor, is regulated by CobB and protein acyltransferase (PAT) [14].  The 
acetylation-deacetylation of Lys180 affected the DNA binding capability of RcsB which affected 
the expression of fhDC genes that positively regulates flagellum biosynthesis [14]. CobB 
deacetylated RcsB can bind DNA as either a homodimer or a heterodimer with RcsA as a 
cofactor to either activate or repress DNA transcription [14].  Since deacetylation exposed a 
positive lysine residue in the DNA binding domain of RcsB which allowed it to bind DNA [14], 
then desuccinylation  may serve the same purpose.  Succinylated and desuccinylated lysine may 
be a stronger regulator for gene transcription since rather than a switch between neutral to 
positive, it is a switch between negative to a positive state.  We investigated RcsB’s DNA 
binding capabilities in vitro using CobB WT and R95M and found that desuccinylation increased 
DNA binding while deacetylation had no significant  affect.   
11 
 
RESULTS/DISSUSSION 
The CobB gene was amplified from E. coli K-12 by PCR and cloned into pET-28a 
expression vector using BamHI and XhoI restriction sites.  The protein is then purified to near 
homogeneity by gravity flow chromatography using nickel affinity chromatography.  Substrates 
were synthesized based on the H3K9 sequence with two Trp on the C-terminus to facilitate 
detection by ultra-violet (UV) light absorption.  Activity was detected by analytical high pressure 
liquid chromatography (HPLC).  Based on sequence alignment, CobB is also a type III sirtuin 
bearing the two conserved residues, Tyr92 and Arg95 (Fig. 3), which is suspected to be 
responsible for Sirt5’s desuccinylation activity.  Site-directed mutagenesis by PCR was used to 
make Y92F, R95M, and Y92F/R95M mutants which were subsequently cloned into pET-28a 
expression vector and purified the same way.   
  
A B 
 
 
CobB – PDB ID: 1S5P 
Sirt5 – PDB 3RIG 
Figure 3. A) Alignment of Sirt5 (gray PDB 3RIG) and CobB (red PDB 1S5P).  B) CobB’s active site has 
two conserved residues, Tyr92 and Arg95, that are conserved in all type III sirtuins.  The residues are 
important for desuccinylation activity of class three sirtuins.  Pymol 1.3 was used to view the structures.   
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The acylated H3K9 peptides were used to investigate the activity of CobB and it’s 
mutants and revealed that wildtype CobB has both deacetylase as well as desuccinylase activity 
while the active site mutants mainly retained their deacetylase activity. Kinetic studies were then 
carried out to quantitatively compare CobB’s activity and assess the importance of the two active 
site residues for desuccinylation.  The kinetics data in Table 2 suggests that wildtype CobB’s 
deacetylase activity is 3 times stronger than it’s desuccinylase activity, while R95M and 
Y92F/R95M  mutants only has a kcat/KM of 22 sec-1 M-1 for succinylated H3K9 peptide, almost 
100 fold lower when compared to wildtype CobB. The Y92F mutant’s desuccinylase activity is 3 
folds better than the other two mutants but is still considerably diminished when compared to 
wildtype CobB’s original activity.  All 3 mutants also suffered a 3 fold difference in terms of its 
deacetylation activity, retaining a similar KM value but a lowered kcat value.  The desuccinylation 
values of the active site mutants were estimated based on a manipulation of the michaelis-menten 
equation. 
Table 2 .  Kinetics data of CobB and mutants with acetylated and succinylated H3K9 (KQTARK*STGGWW) 
peptides.  Activity assay were done in duplicates and analyzed by analytical LC and curved was fitted with 
Kaleidograph v. 3.5.  
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The kinetic’s study had revealed that both residues are critical for desuccinylation activity while 
having very little effect on deacetylation.   This backs up the hypothesis that all type III sirtuins 
that have a conserved Tyr and Arg residue in its activity site should be a desuccucinylase.   
 
Figure 4.  
 32P-NAD activity assay of trypsin digested E. coli total cell lysate.  The peptide solution is then 
treated with either CobB or sirt5 and the resulting acylated ADPR is separated on a TLC.  Lane 1 and 5 is 
acetylated or succinylated H3K9 peptide only, lane 2 and 6 is either CobB or Sirt5 with acetylated or 
succinylated H3K9 peptide.  Lane 3 and 7 is digested lysate only and lane 4 and 8 is the digested lysate with 
CobB and Sirt5.  Acetylated and succinylated ADPR is detectable in the digested cell lysate in lanes 4 and 8 
suggesting that acetylated and succinylated proteins are present in E. coli.   
To investigate the physiological importance of desuccinylation, E. coli cell lysates were 
trypsin digested and the peptides were investigated for the presence of lysine succinylation.  To 
investigate we used 32P-NAD activity assay, a mechanism based method in which NAD 
molecules with a radiolabeled phosphorus will be consumed by sirtuins to generate radiolabeled 
acylated ADPR, to investigate.  In Figure 4, digested cell lysates were treated with either CobB 
or Sirt5 and succinylated ADPR was generated and detected by thin layer chromatography 
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(TLC).  The promiscuity of CobB’s activity makes it difficult to generate a clean acylated ADPR 
spot, hence Sirt5 is used to better detect desuccinylation.   
 Many approaches were used to find a succinylated substrate for CobB.  A literature 
search revealed several acetylated CobB substrates and those were investigated first since in the 
case of Sirt5, CPS1 demonstrated that it can both be a lysine deacetylation and desuccinylation 
target [16].  We had also hypothesized that CobB was important for metabolism since that is the 
main function of CobB in S. enterica.  Acetyl-CoA synthetase (ACS) plays a crucial role in the 
TCA cycle and can be activated by the deacetylation of a lysine residue [11].  We identified 
several metabolic E. coli proteins that were succinylated including 2-oxoglutarate 
dehydrogenase, E1 component (SucA), Serine hydroxymethyltransferase (GlyA),  Histidine 
protein kinase sensor of chemotactic response (CheA), and isocitrate dehydrogenase (ICD) 
by 32P-NAD activity assay (Fig. 5A-C). These proteins suggested that succinylation  and hence 
CobB may be involved in metabolism since it is the only known desuccinylase in E. coli.  
 Literature had suggested that different feeding conditions will affect the acetylation 
levels in the cell [22].  We investigated the importance of CobB under several different 
metabolic conditions by varying the carbon source. A CobB KO strain was grown in minimal 
media with either acetate, succinate or propionate as the sole carbon source and the observed 
phenotype was compared to its parent strain.  Originally it was thought that succinate 
supplemented cells would have the greatest observable phenotype but experimentally acetate and 
propionate supplemented cells demonstrated the greatest growth difference (Fig. 6).  The 
phenotypes demonstrated by the growth curves in Figure 4 can be attributed to either CobB’s 
deacetylation or desuccinylation function.  To further investigate the individual functions of 
CobB, we transformed back either the CobB or R95M gene in the KO strain and repeated the 
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growth experiment.  In Figure 5, transforming back either the CobB or R95M gene only 
demonstrated an effect in acetate and propionate supplemented cells.  In acetate supplemented 
cells, it seems that desuccinylation may actually be detrimental to acetate metabolism. Although 
propionate supplemented cells demonstrated the greatest difference between CobB parent and 
CobB KO strain, it can be concluded that the detriment in growth is most likely the result of 
deacetylation [23].  Cells transformed with either CobB or R95M had similar growth profiles and 
had a shorter lag phase than cells transformed back with H147Y, a catalytic mutant of CobB with 
no activity.    
CobB’s function in E. coli has not been well studied, but two deacetylation substrates 
were identified, CheY and RcsB [14, 24]. Deacetylation of CheY affects chemotaxis while 
deacetylation of RcsB is important in gene regulation [14, 24].  Other possible substrates were 
identified through proteonomic studies by the Zhao group [25].  Succinylated proteins are not 
necessary substrates of CobB since chemical succinylation is a possibility with succinyl-CoA as 
the donor [26-29].   
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Figure 5.  32P-NAD activity assay of possible CobB substrates.  Proteins were expressed in LB media and NiNTA 
purified.  A) SucA-SucD forms a protein complex that is essential for metabolism.  SucA is observed with the 
strongest succinyl spot in lane 8, which is treated by Sirt5.  In lane 9, SucA is treated with CobB and the acylated 
ADPR smear suggests that SucA may have other PTM’s aside from acetyl and succinyl. B) Substrates identified 
by the Zhao lab to be potential CobB targets for desuccinylation.  Only GlyA and ICD have observable succinyl 
ADPR spots. C) CheY was identified as a CobB deactylation target responsible for a role in chemotaxis however, 
interestingly enough, CheA was identified with a stronger succinyl ADPR spot while CheY had no detectable 
acetyl or succinyl ADPR.    
17 
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Figure 6.  Growth Comparison of CobB parent and KO strain grown in minimal media with succintate, acetate, or 
propionate as a carbon source.  Blue lines represent the CobB parent strain and the red line represents CobB KO 
strain.  The circle represents media supplementation with succinate, the triangle represents media supplementation 
with acetate and the square represents media supplementation with propionate.  The error bars are derived from two 
trials.  All the strains observed a lag phase when grown in media with unconventional carbon source.  Succinate only 
had the shortest lag before the exponential phase while acetate and propionate had a lag phase of about 20 hours for 
acetate and over 40 hours for propionate supplemented cells.  While acetate and succinate had similar lag phases, 
propionate demonstrated the largest phenotype for growth.  The parent CobB strain only had a lag phase of over 40 
hours while the KO CobB strain nearly tripled that time. Interestingly, there is no great difference in terms of the 
doubling time during exponential phase or a difference in final OD.   The succinate supplemented cells had only 
final OD differences similar to that of acetate grown cells, but unlike the acetate cells, whose doubling time of the 
KO strain was significantly different than that of the wildtype, the succinate doubling time remains the same 
between both strains.   
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Figure 7.  CobB recovery growth curve.  The circle represents media supplementation with succinate, the 
triangle represents media supplementation with acetate and the square represents media supplementation 
with propionate.  Blue represents the CobB parent strain with the empty pTAC vector.  Red represents the 
CobB KO strain with the empty pTAC vector.  Green represents the CobB KO strain with H147Y 
transformed back.  Purple is CobB KO strain with WT CobB transformed back. Orange is CobB KO strain 
with R95M transformed in.  The H147Y is a catalytic mutant of CobB with activity and it serves as a control 
to eliminate protein association effect of CobB expression.  In acetate supplemented media it appears that 
R95M may be most beneficial to the KO strain implying that desuccinylation is detrimental to acetate 
metabolism.  In succinate supplemented cells CobB does not appear to have any affect in the succinate 
metabolism, while in propionate supplemented cells, the improvement in phenotype may most likely be 
attributed to deacetylation function of CobB since R95M and WT CobB had a similar growth curve.    
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Suspected substrates were expressed and NiNTA purified from ASKA (-) strains which 
bears an N-terminal hexahistidine tag.  The purified proteins were then investigated using the 
above mentioned 32P-NAD activity assay.  Only one protein, RcsB, had showed promising 
results after CobB treatment. RcsB is regulated by PAT and CobB and when it is deacetylated on 
Lys180, it can bind DNA and hence regulate gene expression.  A DNA shift assay in Figure 8 
shows that when RcsB was pretreated with CobB prior to the addition of DNA, it can bind more 
DNA than the untreated RcsB.  What was more interesting was when RcsB was treated with 
R95M, which has deficient desuccinylase activity, it exhibited similar amount of DNA binding 
to the untreated RcsB protein.  This suggests that desuccinylation may be responsible for the 
increased ability of RcsB to bind DNA.  Since R95M has a weaker in vitro deacetylation activity 
than CobB, the difference in DNA binding may still be a result of deacetylation. zWe 
investigated CobB and R95M’s ability to deacetylate and desuccinylate RcsB by pretreating 
RcsB with untagged CobB and R95M.  RcsB was NiNTA purified and eluted with 250 mM of 
imidazole.  Buffer exchange columns were then used to eliminate NAD and to concentrate RcsB.  
In Figure 9, the pretreated RcsB’s were then treated again with CobB or Sirt5 in the 32P-NAD 
activity assay and TLC was used to separate acetyl and succinyl ADPR.  The data suggests that 
CobB can remove more succinyl but less acetyl groups from lysine residues than R95M treated 
RcsB.  This evidence in conjunction with the DNA shift assay strongly suggests that RcsB is 
regulated by desuccinylation rather than by deacetylation.    
In summary, we can conclude that the Arg and Tyr residues are essential to 
desuccinylation of type III sirtuins.  We have demonstrated with our enzymology data that CobB 
can deacetylate and desuccinylate efficiently with only a 3 fold difference.   
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Figure 8. A) DNA shift assay.  RcsB is pretreated with CobB or R95M and then incubated with either 
circular or linear DNA.  There is a noticeable increase in band intensity in lane 4,where CobB treated RcsB 
allows it to bind more DNA.  The Untreated and R95M treated RcsB has similar band intensities for bound 
DNA suggesting that CobB’s dessucinylation activity may be responsible for regulating RcsB rather than 
deacetylation.  B) Percentage of unbound DNA calculated using ImageJ.   
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Figure 9.  TLC of 32P-NAD activity assay of CobB and R95M treated RcsB.  The enzyme treated RcsB is 
treated with either CobB, for the detection of both succinyl and acetyl levels, or Sirt5, for the detection of 
succinyl levels on RcsB.  Lane 8 and lane 9 indicates that CobB treated RcsB has a weaker succinyl ADPR 
spot than and a stronger acetyl ADPR spot than RcsB treated by R95M.  Lane 13 and lane 16 is consistent 
with what was observed in lane 8 and 9.  The data suggests that CobB can remove more succinyl groups off of 
RcsB while R95M can remove more acetyl groups.   
Growth comparison between CobB and CobB KO strain under different nutrient conditions, 
suggests that CobB is most likely involved in many metabolic pathways.  CobB had the strongest 
effect in propionate supplemented media but recovery experiments with mutant CobB, R95M, to 
WT CobB, suggesting that  depropionylation of propionyl-CoA synthetase (PrpE) is likely the 
cause of the lag phase difference [23].  Propionyl is very similar to acetyl. Even though we do 
not have kinetics with H3K9 Propionyl, we can hypothesize that it would be very similar to 
H3K9 AC data.  Although it appears that CobB is important in some metabolic pathways, the 
effect of it’s desuccinylase activity in metabolic regulation is unclear.  However, in terms of gene 
regulation, we provided strong evidence to support that RcsB is regulated by CobB through 
desuccinylase activity rather than deacetylase activity. More work is needed in the identification 
of succinyltransferases, to demonstrate that, like lysine acetylation, lysine succinylation is also a 
reversible reaction used to regulate gene transcription.   
24 
 
METHODS  
Cloning, expression, and purification of CobB amd Mutants. CobB gene was PCR 
amplified from E.coli K-12 and cloned into pET-28a(+) vector with BamHI and XhoI restriction 
sites.  The CobB expression vector was then introduced into an E. coli BL21 with pRARE2.  
Successful transformants were selected by plating the cells on kanamycin (50 mg mL-1) and 
chloramphenicol (20 mg mL-1) luria broth (LB) plates.  Single colonies were selected and grown 
in LB with kanamycin (50 mg mL-1) and chloramphenicol (20 mg mL-1) overnight at 37oC.  On 
the following day the cells were then subcultured (1:1000 (v/v)) into a 2 L LB with kanamycin 
(50 mg mL-1) and chloramphenicol (20 mg mL-1).  The cells were induced with 500 µM of 
isopropyl β-D-1-thiogalactopyranoside (IPTG) at OD600 of 0.6 and grown overnight at 15oC, 200 
rpm.  The cells were harvested by centrifugation at 6000 rpm for 10 minutes at 4oC (Beckman 
Coulter Refrigerated Floor Centrifuge) and passed through an EmulsiFlex-C3 cell disruptor 
(AVESTIN, Inc.) 3 times.  Cellular debris was removed by centrifuging at 20000 rpm for 30 
minutes at 4oC (Beckman Coulter).  The CobB was then purified using gravity flow Ni-affinity 
chromatography (Sigma) and dialyzed into 25 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT, 10% 
(v/v) glycerol.  The proteins were then aliquoted and kept frozen at -80oC.  The active site and 
catalytic mutant of CobB, Y92F, R95M, Y92F?R92M and H147Y, were made by PCR site 
directed mutagenesis and expressed and purified the same way as wildtype CobB.   
Synthesis of acyl peptides. Solvents were purchased from Fisher Scientific unless 
otherwise specified and peptide synthesis reagents and Fmoc-protected amino acids and 
derivatives were purchased from Creosalus Inc.       
The H3K9 (NH2-KQTARK*STGGWW-COOH) backbone was prepared using standard 
solid phase peptide synthesis (SPPS) at room temperature (RT).  Wang resins SS (100-200 mesh, 
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1% DVB, 10 mmole/g) were placed into a peptide synthesis vessel along with 5 mL of 
anhydrous dichloromethane (DCM) for 5 hours.  The first activated amino acid solution was 
freshly prepared with 0.32 mmoles of Fmoc-W-OH, 0.32 mmoles of O-benzotriazole-N,N,N’,N’-
tetramethyl-uronium-hexafluoro-phosphate (HBTU), 0.133 mmoles of 4-dimethylaminopyridine 
(DMAP), 0.64 mmoles of diisopropylethylamine (DIEA, added last) and an appropriate amount 
of anhydrous N,N’-dimethylformamide (DMF).  The resin was incubated with the solution 
overnight at RT. The resins were then washed with DMF (5 times) before incubating with a 
cocktail of acetic anhydride, pyridine and DMF (2:1:3 ratio (v/v)) for 30 minutes to block 
remaining amino groups on the resin.  Kaiser test was used to test the success of the coupling.  
Once coupling was confirmed, 20% (v/v) piperidine in DMF was used to remove Fmoc.  All 
subsequent activated amino acid derivatives were freshly prepared with 0.24 mmoles of the 
amino acid, 0.24 mmole of HBTU, 0.21 mmole of N-hydroxybenzotriazole (HOBT), 0.48 
mmole of DIEA in DMF and reaction time was 2 hours at RT.   
The lysine to be modified by different acyl groups (K*) was protected with allyl carbamate 
(Alloc) on the side chain while the N-terminal K was protected by Boc.  After all the peptide 
coupling steps were done on the resin, the Alloc group was removed by incubating the resin in a 
cocktail of DCM, morpholine (Sigma, 2.5%) and glacial acetic acid (5%) with a 1:1 weight ratio 
of the original resin and tetrakis(triphenylphosphine)palladium(0) for 4 hours under nitrogen. 
Several washes of 0.5% (v/v) DIEA in DCM and 0.02 M of diethyldicarbamate in DMF were 
carried out to remove the palladium.  The resin was then incubated with solutions for putting on 
different acyl groups. The acylation solutions contained 0.24 mmoles of the different groups 
(acetic anhydride, succinic anhydride), 0.24 mmole of HBTU, 0.21 mmole of HOBT, 0.48 
mmole of DIEA and DMF.  The resin was then washed with DMF and the peptides were cleaved 
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with a mixture of trifluoroacetic acid (TFA), 5% (v/v) water, 5% (w/v) phenol, 2.5% (v/v) 
ethanedithiol and 5% (v/v) thioanisole.  TFA was removed from the filtered peptide solution and 
the peptides were precipitated out by the addition of ether and lyophilized.  The crude peptides 
were dissolved in water and purified by HPLC (Beckman Coulter System Gold 125P solvent 
module and 168 Detector) using a TARGA C18 column (250 x 20 mm, 10 µM, Higgins 
Analytical, Inc.) with mobile phase A (water with 0.1% (v/v) TFA) and B (acetonitrile with 0.1% 
(v/v) TFA) at a gradient of 20% B to 100% B in 50 minutes and a flow rate of 10 mL/min.  The 
peptides were monitored at 215 nm and 280 nm and fractions were collected.  LCMS 
(SHIMADZU LCMS-QP8000α with a Sprite TARGA C18 column (40 × 2.1 mm, 5 µm, Higgins 
Analytical, Inc.) was used to confirm the peptide mass and high purity fractions were 
lyophilized. The solvents used in LCMS were water with 0.1% (v/v) formic acid and acetonitrile 
with 0.1% (v/v) formic acid.  
HPLC assay and kinetics. Activity of CobB was determined using HPLC, by quantifying 
the modified and unmodified H3K9 peptide.  The reaction contained 20 mM of Tris pH 8.0, 1 
mM DTT, 20 µM H3K9 modified peptide, 1 mM of NAD and 0.5 µM of CobB and was 
incubated at 37oC for 1 hour.  The reaction was quenched with 1 volume of 10% (v/v) TFA and 
spun down for 10 minutes at 18,000 g (Beckman Coulter Microfuge) to separate the enzyme 
from the reaction. The supernatant was then analyzed by HPLC.   
The kcat and Km values were determined using HPLC to quantify the amount of product 
formed with varying concentrations of the modified peptide with 1 mM of NAD, 20 mM Tris pH 
8.0, 100 mM NaCl, 1 mM DTT, 0.5 µM of CobB  (acetyl and succinyl H3K9 peptide).  Peptide 
concentration used for H3K9 acetyl was 5, 8, 10, 12, 16, 32, 40, 67 and 268 µM and Succinyl 
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was 2, 3, 4, 6, 8, 12, 16, 24, 32 and 128 µM with an incubation time of 1 and 2 minutes, 
respectively for wildtype CobB and 3 mins for deacetylation for the mutants.  Peptide 
concentration used for desuccinylation activity estimation of CobB mutants was 256 µM for 60 
mins at 37oC.   The quenched reactions were then analyzed via HPLC using a reverse phase 
analytical column (Kinetex XB-C18 100A, 75x 4.60 mm, 2.6 um, Phenomenex) with a 0% to 
70% B gradient in 20 minutes at 0.5 mL/min.  The acetyl and succinyl peptide has a very close 
retention time to the unmodified peptide. The product peak and the substrate peaks were both 
quantified and converted to initial rates , which were then plotted against the modified peptide 
concentration and fitted using the Kaleidagraph program.   
32P-NAD activity assay. The reaction contained 50 mM Tris pH 8.0, 150 mM NaCl, 10 mM 
DTT, 60 µM H3K9 modified peptide, 0.1 µCi of 32P-NAD (American Radiolabeled 
Chemicals, ARP 0141-250 µCi) and 1 µM of CobB or SirT5, and was incubated at 37oC for 1 
hour.  
E. coli whole cell lysate (100 µL) was first denatured with 6 M of Urea, 15 mM of DTT at 
37oC for 1 hour.  Then it was alkylated with 50 mM of iodoacetamide in the dark at RT for 1 
hour.  The solution was then diluted so that the final concentration of urea was less than 0.75 M 
and digested with 0.1 µg/µL trypsin and 50 mM Tris pH 7.4, and 1 mM CaCl2 overnight at 37oC.  
The digest was quenched with 10% (v/v) TFA to a final pH of 2 to 3 and desalted with a Waters 
C18 Sep-Pak column.  The peptides were eluted 5 times with 1 mL of 50% (v/v) ACN/0.1% 
(v/v) TFA and lyophilized. The peptides were then solubilized in 50 µL of water and 1 µL was 
used in the 32P-NAD assay under conditions described above. The reaction was incubated at 
37oC for 1 hour and 0.5 µL of the reaction mixture was spotted onto a polyester backed silica 
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plate (100 µm thick, Waters).  After the spots were dried, the plate was run for 6 cm in 30:70 
(v/v) 1M ammonium bicarbonate: 95% ethanol.  The plate was dried and exposed overnight in a 
PhosphorImaging screen (GE Healthcare). The signal was detected using a STORM860 
phosphorimager (GE Healthcare).    
 Growth curve.  Chemically competent CobB parent and KO E. coli cells, transformed 
with either empty pTAC vector or pTAC-H147Y, pTAC-CobB, pTAC-R95M  plasmids, are 
grown in a LB starter culture with 100 mg mL-1 of ampicillin at 37oC for 24 hours.   The starter 
culture is then spun down at 4000 rpm and 4oC for 15 mins and washed twice with minimal 
media.  The   cells are resuspended again in minimal media with no supplements and placed in a 
shaker incubator for 2 hours at 37oC and 200 rpm. This step serves to deplete the cell of LB 
nutrients that will interfere with the growth curve later on.  After the 2 hour, cells are normalized 
to an OD600nm of 1.0 and subcultured into minimal media with 2 mM MgSO4, 0.1 mM CaCl2, 34 
µg µL-1 of thiamine, 0.003% of FeSO4, 100 mg mL-1Ampicillin, 1 mM IPTG, and either 20 mM  
of sodium acetate, 16.5 mM  of sodium succinate or 22 mM of sodium propionate with a starting 
OD600nm of either 0.01, 0.05 or 0.1.  The OD600nm of cells are monitored every 2 hour intervals 
for succinate, 4-8 hour intervals for acetate and 6-12 hour intervals for propionate supplemented 
cells.  Ampicillin and IPTG are replenished every 48 hours to enable selection pressure for the  
pTAC plasmid.  When cells reach the stationary phase they are spun down at 4000 rpm for 15 
mins at 4oC and stored for PCR analysis.  Using sequencing primers, N26 and C24, for the pTAC 
plasmid we use PCR to ensure that the cells still have the plasmid during the long period of 
growth.   
 DNA shift assay. NiNTA purified RcsB (final 2.5 µM)  is incubated with 2.5 µM final 
concentration of CobB or R95M for 1 hour at 37oC in 25 mM of sodium phosphate buffer pH 
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8.0, 100 mM of NaCl, and 1 mM of NAD.  After the hour, 5 µg µL-1 of pTAC plasmid or 20 µg 
µL-1 of an 800 bp PCR fragment is added and the mixture is incubated at room temperature for 1 
hour before the reaction is quenched with 5 µL of DNA dye. The reaction is loaded onto a 0.7% 
DNA gel with ethidium bromide and run at 150 V for 40 mins.  The result is visualized by a UV 
light box and picture is taken by a canon camera. 
 CobB and R95M pretreatment of RcsB.  Histag pTEV was incubated with CobB or 
R95M at 30oC for 1 hour  in 25 mM of TRIS pH 8.0, 100 mM NaCl and 1 mM of DTT.     The 
mixture is then incubated with 100 uL of NiNTA (Qiagen) resin for an hour at 4oC to remove all 
histag proteins leaving just untagged protein. The mixture is loaded onto a 1.5 mL spin column 
and the resin was separated from the mixture.   Then the untagged proteins were incubated with 
histagged RcsB at a ratio of 1:10 and 1 mM NAD for an hour at 37oC.  After the hour 100 uL of 
NiNTA (Qiagen) was incubated with the mixture for 1 hour at 4oC and loaded onto a spin 
column.  The resin is then washed twice with 10 mM imidazole and RcsB is eluted with 250 mM 
of imidazole.  The elution is then loaded onto a0.5 mL buffer exchange column (Millipore) to 
remove NAD and concentrate the sample.  Final buffer content is 25 mM TRIS pH 8.0, and100 
mM NaCl.  The CobB and R95M treated protein concentration is normalized to 24 µM and used 
in a 32P-NAD activity assay with 2.5 µM final concentration of either CobB or SirT5 for 1 hour 
at 37oC. The rest is the same as 32P-NAD activity assay mentioned about.    
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CHAPTER 3: PLASMODIUM FALCIPARUM SIR2A 
PREFERENTIALLY HYDROLYZES MEDIUM AND LONG CHAIN 
FATTY ACYL LYSINE 
 
ABSTRACT 
Plasmodium falciparum Sir2A (PfSir2A), a member of the sirtuin family of nicotinamide 
adenine dinucleotide-dependent deacetylases, has been shown to regulate the expression of 
surface antigens to evade the detection by host immune surveillance. It is thought that PfSir2A 
achieves this by deacetylating histones. However, the deacetylase activity of PfSir2A is weak. 
Here we present enzymology and structural evidences supporting that PfSir2A catalyzes the 
hydrolysis of medium and long chain fatty acyl groups from lysine residues more efficiently. 
Furthermore, P. falciparum proteins are found to contain such fatty acyl lysine modifications that 
can be removed by purified PfSir2A in vitro. Together, the data suggest that the physiological 
function of PfSir2A in antigen variation may be achieved by removing medium and long chain 
fatty acyl groups from protein lysine residues. The robust activity of PfSir2A would also 
facilitate the development of PfSir2A inhibitors, which may have therapeutic value in malaria 
treatment. 
Published in ACS Chem Bio. 
Accession number 21992006 
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Sirtuins are a family of enzymes known as nicotinamide adenine dinucleotide (NAD)-
dependent deacetylases [30, 31]. They regulate a variety of biological processes, including 
transcription and metabolism [32, 33]. Plasmodium falciparum (P. falciparum) contains two 
sirtuins, PfSir2A and PfSir2B [34]. It was shown that these two sirtuins regulate the expression 
of surface antigens to evade the detection by host immune surveillance [35, 36]. Thus, inhibiting 
these sirtuins may help fight malaria. It was thought that PfSir2A and PfSir2B achieve this 
physiological function by deacetylating histones. In vitro studies on PfSir2A showed that it has 
deacetylase activity [37]. However, the activity was weak compared to several other sirtuins 
[38], such as human Sirt1 and yeast Sir2. It was also reported that PfSir2A had ADP-
ribosyltransferase activity [37]. However, several reports questioned whether the ADP-
ribosyltransferase activity of sirtuins was physiologically relevant since the measured activity of 
several sirtuins was weak [39, 40]. 
In addition to acetylation, lysine propionylation and butyrylation have been reported as 
posttranslational modifications that occur on proteins, including histones [23, 41, 42]. Many fatty 
acyl-CoA molecules exist in cells as metabolic intermediates. If the shorter chain fatty acyl CoA 
molecules (acetyl-CoA, propionyl-CoA, and butyryl-CoA) are used as acyl donors to modify 
proteins, it is possible that longer chain fatty acyl-CoA molecules can also be used to modify 
protein. Given that PfSir2A’s deacetylase activity is weak, we set out to investigate whether 
longer chain fatty acyl lysine can be accepted as better substrates by PfSir2A.  
The PfSir2A gene was de novo synthesized. The protein was expressed in E. coli and 
affinity purified to near homogeneity. For substrates, we synthesized histone H3 peptides bearing 
acetyl, butyryl, octanoyl, and myristoyl groups on Lys9.  To facilitate the detection of the 
peptides by ultra-violet (UV) light absorption, two Trp residues were added to the C-terminal of 
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the peptides. A high-pressure liquid chromatography (HPLC) assay was used to monitor the 
activity of PfSir2A on these different acyl peptides. Interestingly, all four acyl peptides could be 
hydrolyzed (Fig. 10a). The butyryl, octanoyl and myristoyl peptides could be hydrolyzed more 
efficiently than the acetyl peptide. The myristoyl peptides appeared to be hydrolyzed most 
efficiently.  
To quantitatively compare the activity of PfSir2A on different acyl peptides, kinetic studies 
were carried out. The kinetics data (Table 3) suggested that acetyl H3K9 peptide was the least 
efficient substrate among the four acyl peptides tested, with a kcat/Km of 26 s-1M-1. The kcat/Km 
value for deacetylation was comparable to that reported by Sauve and coworkers [38]. The 
butyryl, octanoyl, and myristoyl peptides were hydrolyzed with much higher catalytic 
efficiencies. In particular, the catalytic efficiencies for the hydrolysis of myristoyl peptide were 
more than 300-fold higher than that for the hydrolysis of acetyl peptide. The Km value for the 
myristoyl peptide was lower than 1 µM (PfSir2A was saturated with 2 µM of the myristoyl 
peptide. The Km value could not be accurately determined because of the detection limit at low 
substrate concentrations). The enzymology data demonstrated that PfSir2A preferentially 
hydrolyzes medium and long chain fatty acyl lysine. 
Table 3. Kinetics data for PfSir2A on different acyl peptides 
substrate kcat (s-1) Km for peptide (µM) kcat/Km (s-1M-1) 
H3K9 acetyl 0.001 ± 0.0002 39 ± 9 2.6 x 101 
H3K9 butyryl 0.001 ± 0.0002 8  ± 1 1.6 × 102 
H3K9 octanoyl 0.001 ± 0.004 1.2 ± 0. 3 9.2 × 102 
H3K9 myristoyl 0.01± 0.002 <1.0a >1.0 × 104 
a. The Km value cannot be accurately determined due to the detection limit when substrate concentration was lower 
than 1 µM. 
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Figure 10. PfSir2A could hydrolyze medium and long chain fatty acyl lysine more efficiently than acetyl 
lysine. (a) Overlaid HPLC traces showing PfSir2A-catalyzed hydrolysis of different fatty acyl lysine peptides. 
Acyl peptides were used at 20 µM, PfSir2A at 1 µM, and NAD at 500 µM. The corresponding synthetic 
peptide without any acyl lysine modification (H3K9WW unmodified) was used as the control to indicate the 
position of the hydrolysis product formed. (b) 32P-NAD assay could detect the presence of medium or long 
chain fatty acyl lysine modifications on P. falciparum proteins. PfSir2A were incubated with 32P-NAD and 
synthetic peptides bearing different acyl modifications. Negative controls were reactions without PfSir2A or 
peptides. The reactions were resolved by TLC and detected by autoradiography. With P. falciparum peptides 
(last two lanes), the acyl ADPR spot formed was similar to the C8-C14 acyl ADPR, suggesting that such fatty 
acyl groups were present and could be removed by PfSir2A. 
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Figure 11. Structural basis for the recognition of myristoyl lysine by PfSir2A. (a) Overall structure of 
PfSir2A. The Fo-Fc map at 1.6σ shows the H3K9 myristoyl peptide (green) and NAD (yellow) at the active 
site. (b) The structural alignment between Sir2Tm (blue) and PfSir2A (grey). The positions of H3K9 
myristoyl peptide and NAD in PfSir2A were similar to the positions of acetyl peptide and NAD in Sir2Tm. (c) 
Hydrogen bonding interactions between the H3K9 myristoyl peptide (green) and PfSir2A (grey). (d) 
Structural alignment between PfSir2A-AMP (cyan, PDB code: 3JWP) and PfSir2A-myrH3K9 showed that 
the binding of the substrate peptide myrH3K9 drove PfSir2A from an inactive open state to an active close 
state. (e) PfSir2A had a long open hydrophobic tunnel which accommodated fatty acyl groups. PfSir2A 
surface representation: grey; myristoyl lysine: green; hydrophobic residues: orange. 
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To understand the structural basis for PfSir2A’ preference for longer chain fatty acyl 
groups, we co-crystallized PfSir2A with an H3K9 myristoyl peptide to generate the PfSir2A-
H3K9 myristoyl complex. The co-crystal was then soaked briefly in an NAD solution to obtain a 
ternary complex of PfSir2A with H3K9 myristoyl peptide and NAD. The structures were solved 
using molecular replacement with the deposited PfSir2A structure PDB 3JWP as the search 
model. The overall structure of PfSir2A was similar to other sirtuins, containing a small Zn-
binding domain and a large Rossmann fold domain (Fig.11a) [43-46]. The two substrates, H3K9 
myristoyl peptide and NAD, bound to the clefts between the two domains. This binding mode of 
the two substrates was similar with the reported ternary complex structures of other sirtuins. For 
instance, the peptide substrates of the Thermotoga maritima Sir2 (Sir2Tm, PDB 2H4F, one of 
the first sirtuin ternary complex structureswith both NAD and acetyl peptide bound) and PfSir2A 
superimposed well (Fig. 11b) [47]. The interactions between PfSir2A and H3K9 myristoyl 
peptide mainly came from main chain hydrogen bonds (Fig. 11c), in agreement with other 
studies of sirtuins [47]. Compared with the structure without any acyl peptide bound (PDB 
3JWP), the binding of H3K9 myristoyl peptide to PfSir2A caused the Zn-binding domain to 
rotate clockwise to the Rossmann fold domain, so that PfSir2A moved from an open state to a 
close state which is similar to that observed in Sir2Tm (Fig. 11d) [47]. However, different from 
Sir2Tm, PfSir2A had a long open hydrophobic tunnel that accommodated the myristoyl group 
(Fig.11e). The hydrophobic tunnel was surrounded by several hydrophobic residues (Ile45, 
Trp56, Ile77, Ile80, Ile84, Ile90, Val116, Val135, Phe136, Ile178, and Leu181). This structure 
feature suggested that PfSir2A was optimized for recognizing fatty acyl groups. 
The enzymology and structural data led to the hypothesis that PfSir2A may function to 
remove medium and long chain fatty acyl groups in malaria parasite. Protein lysine 
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myristoylation has been reported to occur on several mammalian proteins [48, 49]. To test 
whether malaria parasite proteins have medium or long chain fatty acyl modifications on lysine 
residues, a sensitive assay was developed to detect the presence of fatty acyl lysine in malaria 
parasites. With the use of 32P-NAD, the formation of fatty acylated ADP-ribose (ADPR) in 
PfSir2A-catalyzed defatty acylation of synthetic acyl peptides can be detected after thin-layer 
chromatography (TLC) separation and autoradiography. Longer chain fatty acyl ADPR species 
were more hydrophobic and thus moved faster than shorter chain fatty acyl ADPR species (Fig. 
10b). Notably, most NAD molecules were consumed when octanoyl and myristoyl peptides were 
incubated with PfSir2A, while there were still NAD molecules left when acetyl and butyryl 
peptides were incubated with PfSir2A.  This observation confirmed the kinetic studies that 
octanoyl and myristoyl peptides were more efficient substrate for PfSir2A. When total protein 
extracts of malaria parasites were incubated with 32P-NAD and PfSir2A, the formation of a 
longer chain fatty acyl ADPR was detected. The position of the fatty acyl ADPR was similar to 
that formed the reactions with synthetic octanoyl and myristoyl peptides, suggesting that fatty 
acyl group on P. falciparum proteins should have a similar chain length. The intensity of the 
fatty acyl ADPR spot was weak, suggesting that the concentration of the fatty acyl peptide in our 
P. falciparum protein extract was low. However, we could repeatedly detect this spot using 
the 32P-NAD assay. In addition, compared with the negative control without PfSir2A, the 
intensity for the acetyl ADPR spot did not increase. Therefore, PfSir2A’s deacetylase activity 
could not be detected using P. falciparum protein extract, but the activity of removing longer 
fatty acyl groups could be detected. 
In summary, our enzymology and structural data demonstrated that PfSir2A was more 
efficient at removing medium and long chain fatty acyl groups than acetyl groups from peptides. 
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Although it is known that other sirtuins can also hydrolyze propionyl and butyryl lysine, but the 
activity is typically weaker than the hydrolysis of acetyl lysine [50, 51]. Therefore, our work 
demonstrates for the first time that longer fatty acyl lysines can be the preferred substrate for a 
sirtuin.  The biochemical data suggest that P. falciparum proteins contain such fatty acyl lysine 
modifications, which can be removed by PfSir2A in vitro. The data imply that the biological 
function of PfSir2A may be achieved by its activity of removing medium and long chain fatty 
acyl groups. The detailed structures of the fatty acyl groups and the abundance of such 
modifications in comparison to the well-known acetyl lysine modification await future studies. 
The finding that PfSir2A could remove longer fatty acyl groups suggests that other sirtuins, 
especially those that have weak or no deacetylase activity, may also have this activity. Sirtuins 
should therefore be called “NAD-dependent deacylases”, instead of “NAD-dependent 
deacetylases”. The discovery of a robust activity for PfSir2A will also facility the development 
of PfSir2 inhibitors, which may have therapeutic value in treating malaria. 
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METHODS  
Cloning, expression, and purification of PfSir2A. PfSir2A gene was custom synthesized 
by Genscript.  The sequence was codon optimized for overexpression in E. coli and cloned into 
pET-28a(+) vector with BamHI and XhoI restriction sites.  The PfSir2A expression vector was 
then introduced into an E. coli BL21 with pRARE2.  Successful transformants were selected by 
plating the cells on kanamycin (50 mg mL-1) and chloramphenicol (20 mg mL-1) luria broth (LB) 
plates.  Single colonies were selected and grown in LB with kanamycin (50 mg mL-1) and 
chloramphenicol (20 mg mL-1) overnight at 37oC.  On the following day the cells were then 
subcultured (1:1000 (v/v)) into a 2 L LB with kanamycin (50 mg mL-1) and chloramphenicol (20 
mg mL-1).  The cells were induced with 500 µM of isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at OD600 of 0.6 and grown overnight at 15oC, 200 rpm.  The cells were harvested by 
centrifugation at 6000 rpm for 10 minutes at 4oC (Beckman Coulter Refrigerated Floor 
Centrifuge) and passed through an EmulsiFlex-C3 cell disruptor (AVESTIN, Inc.) 3 times.  
Cellular debris was removed by centrifuging at 20000 rpm for 30 minutes at 4oC (Beckman 
Coulter).  The PfSir2A was then purified using gravity flow Ni-affinity chromatography (Sigma) 
and dialyzed into 25 mM Tris pH 8.0, 50 mM NaCl, 1 mM DTT, 10% (v/v) glycerol.  The 
proteins were then aliquoted and kept frozen at -80oC. For crystallization, the 6-His tag of 
PfSir2A was removed by overnight incubation at 4°C with 30 unit mL-1 of thrombin 
(Haematologic Technologies Inc.), followed by Ni-affinity column purification to separate the 
undigested PfSir2A from the digested one. Then, the tag-free PfSir2A was further purified by 
FPLC with SuperdexTM 75 column (Bio-rad), dialyzed into crystallization buffer (20 mM 
HEPES, pH 7.1, 20 mM NaCl, 5 mM DTT, 3% (v/v) glycerol), concentrated into 10 mg mL-1, 
flash frozen by liquid nitrogen, and stored at -80 °C for crystallization. 
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Synthesis of acyl peptides. Solvents were purchased from Fisher Scientific unless 
otherwise specified and peptide synthesis reagents and Fmoc-protected amino acids and 
derivatives were purchased from Creosalus Inc.       
The H3K9 (NH2-KQTARK*STGGWW-COOH) backbone was prepared using standard 
solid phase peptide synthesis (SPPS) at room temperature (RT).  Wang resins SS (100-200 mesh, 
1% DVB, 10 mmole/g) were placed into a peptide synthesis vessel along with 5 mL of 
anhydrous dichloromethane (DCM) for 5 hours.  The first activated amino acid solution was 
freshly prepared with 0.32 mmoles of Fmoc-W-OH, 0.32 mmoles of O-benzotriazole-N,N,N’,N’-
tetramethyl-uronium-hexafluoro-phosphate (HBTU), 0.133 mmoles of 4-dimethylaminopyridine 
(DMAP), 0.64 mmoles of diisopropylethylamine (DIEA, added last) and an appropriate amount 
of anhydrous N,N’-dimethylformamide (DMF).  The resin was incubated with the solution 
overnight at RT. The resins were then washed with DMF (5 times) before incubating with a 
cocktail of acetic anhydride, pyridine and DMF (2:1:3 ratio (v/v)) for 30 minutes to block 
remaining amino groups on the resin.  Kaiser test was used to test the success of the coupling.  
Once coupling was confirmed, 20% (v/v) piperidine in DMF was used to remove Fmoc.  All 
subsequent activated amino acid derivatives were freshly prepared with 0.24 mmoles of the 
amino acid, 0.24 mmole of HBTU, 0.21 mmole of N-hydroxybenzotriazole (HOBT), 0.48 
mmole of DIEA in DMF and reaction time was 2 hours at RT.   
The lysine to be modified by different acyl groups (K*) was protected with allyl carbamate 
(Alloc) on the side chain while the N-terminal K was protected by Boc.  After all the peptide 
coupling steps were done on the resin, the Alloc group was removed by incubating the resin in a 
cocktail of DCM, morpholine (Sigma, 2.5%) and glacial acetic acid (5%) with a 1:1 weight ratio 
of the original resin and tetrakis(triphenylphosphine)palladium(0) for 4 hours under nitrogen. 
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Several washes of 0.5% (v/v) DIEA in DCM and 0.02 M of diethyldicarbamate in DMF were 
carried out to remove the palladium.  The resin was then incubated with solutions for putting on 
different acyl groups. The acylation solutions contained 0.24 mmoles of fatty acids of different 
chain lengths (acetic anhydride, butyric acid, octanoic acid, or myristic acid), 0.24 mmole of 
HBTU, 0.21 mmole of HOBT, 0.48 mmole of DIEA and DMF.  The resin was then washed with 
DMF and the peptides were cleaved with a mixture of trifluoroacetic acid (TFA), 5% (v/v) water, 
5% (w/v) phenol, 2.5% (v/v) ethanedithiol and 5% (v/v) thioanisole.  TFA was removed from the 
filtered peptide solution and the peptides were precipitated out by the addition of ether and 
lyophilized.  The crude peptides were dissolved in water and purified by HPLC (Beckman 
Coulter System Gold 125P solvent module and 168 Detector) using a TARGA C18 column (250 
x 20 mm, 10 µM, Higgins Analytical, Inc.) with mobile phase A (water with 0.1% (v/v) TFA) 
and B (acetonitrile with 0.1% (v/v) TFA) at a gradient of 20% B to 100% B in 50 minutes and a 
flow rate of 10 mL/min.  The peptides were monitored at 215 nm and 280 nm and fractions were 
collected.  LCMS (SHIMADZU LCMS-QP8000α with a Sprite TARGA C18 column (40 × 2.1 
mm, 5 µm, Higgins Analytical, Inc.) was used to confirm the peptide mass and high purity 
fractions were lyophilized. The solvents used in LCMS were water with 0.1% (v/v) formic acid 
and acetonitrile with 0.1% (v/v) formic acid.  
HPLC assay and kinetics. Activity of PfSir2A was determined using HPLC, by quntifying 
the modified and unmodified H3K9 peptide.  The reaction contained 20 mM of Tris pH 8.0, 1 
mM DTT, 20 µM H3K9 modified peptide, 1 mM of NAD and 1 µM of PfSir2A and was 
incubated at 37oC for 1 hour.  The reaction was quenched with 1 volume of 10% (v/v) TFA and 
spun down for 10 minutes at 18,000 g (Beckman Coulter Microfuge) to separate the PfSir2A 
from the reaction. The supernatant was then analyzed by HPLC.   
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The kcat and Km values were determined using HPLC to quantify the amount of product 
formed with varying concentrations of the modified peptide with 1 mM of NAD, 20 mM Tris pH 
8.0, 50 mM DTT, 0.5 µM of PfSir2A  (butyryl, octanoyl and myristoyl H3K9 peptide), and 1 µM 
of PfSir2A was used for acetyl H3K9.  Peptide concentration used for H3K9 acetyl and butyryl 
were both 2, 4, 8, 16, 32, 64, 128, and 256 µM with an incubation time of 40 and 20 minutes, 
respectively.  Peptide concentration used for H3K9 octanoyl was 1, 2, 4, 8, 16, 32, 64, and 128 
µM with an incubation time of 15 minutes. Peptide concentration used for H3K9 myristoyl was 
1, 2, 3, 4, 5, 6, 8, and 16 µM with an incubation time of 1 minute. The stock solutions of the 
different peptides were made in different solvents.  H3K9 acetyl was stored in water while the 
longer fatty acyl peptides, butyryl and octanoyl were stored in 1:1 (v/v) DMSO:water solutions.  
The myristoyl peptide is especially hydrophobic and was stored in DMSO.  If only water was 
used to dissolve them, the peptides would stick to the plastic tubes used and led to errors in the 
peptide concentration. The final concentrations of DMSO in the assays varied from 0 to 10% by 
volume.   The quenched reactions were then analyzed via HPLC using a reverse phase analytical 
column (Sprite TARGA C18, 40 × 2.1 mm, 5 µm, Higgins Analytical, Inc.) with a 0% to 70% B 
gradient in 8 minutes at 1 mL/min.  The acetyl peptide has a very close retention time to the 
unmodified peptide and a different column was used to separate the peaks (Kinetex XB-C18 
100A, 75x 4.60 mm, 2.6 um, Phenomenex).   The product peak and the substrate peaks were 
both quantified and converted to initial rates , which were then plotted against the modified 
peptide concentration and fitted using the Kaleidagraph program.   
32P-NAD assay. The reaction contained 50 mM Tris pH 8.0, 150 mM NaCl, 10 mM DTT, 
60 µM H3K9 modified peptide, 0.1 µCi of 32P-NAD (American Radiolabeled Chemicals, ARP 
0141-250 µCi) and 1 µM of Pfsir2A and was incubated at 37oC for 1 hour.  
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P. falciparum whole cell lysate (100 µL) was first denatured with 6 M of Urea, 15 mM of 
DTT at 37oC for 15 minutes.  Then it was alkylated with 50 mM of iodoacetamide in the dark at 
RT for 1 hour.  The solution was then diluted so that the final concentration of urea was less than 
0.75 M and digested with 0.1 µg/µL trypsin and 50 mM Tris pH 7.4, and 1 mM CaCl2 overnight 
at 37oC.  The digest was quenched with 10% (v/v) TFA to a final pH of 2 to 3 and desalted with 
a Waters C18 Sep-Pak column.  The peptides were eluted 5 times with 1 mL of 90% (v/v) 
ACN/0.1% (v/v) TFA and lyophilized. The peptides were then solubilized in 50 µL of water and 
1 µL was used in the 32P-NAD assay under conditions described above. The reaction was 
incubated at 37oC for 15 minutes and 1 µL of the reaction mixture was spotted onto a polyester 
backed silica plate (100 µm thick, Waters).  After the spots were dried, the plate was run for 6 
cm in 30:70 (v/v) 1M ammonium bicarbonate: 95% ethanol.  The plate was dried and exposed 
overnight in a PhosphorImaging screen (GE Healthcare). The signal was detected using a 
STORM860 phosphorimager (GE Healthcare).    
Crystallization, data collection, and structural refinement.  PfSir2A was mixed with 
H3K9 myristoyl peptide at the protein:peptide ratio of 1:10, diluted into 3 mg mL-1 with 
crystallization buffer, and incubated on ice for 30-60 minutes. Crystals were grown at room 
temperature with hanging drop vapor diffusion method at the condition of 16% PEG 3350, 0.1 M 
NaF, 7% formamide. PfSir2A-H3K9 myristoyl co-crystals were soaked in the cryoprotectant 
solution (18% PEG 3350, 0.1 M NaF, 10% formamide, 15% glycerol) with 10 mM NAD for 2-
10 minutes at room temperature immediately before data collection. All data were collected at 
CHESS (Cornell High Energy Synchrotron Source) F2 station. The data were processed using 
the programs HKL2000 [52]. Using the program Molrep from the CCP4 suite of programs [53], 
the structures were solved by molecular replacement with PfSir2A-AMP structure (PDB code: 
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3JWP) as the searching template. Refinement and model building were performed with 
REFMAC5 and COOT from CCP4. The X-ray diffraction data collection and structure 
refinement statistics were shown in Table 4. 
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 Table 4. Crystallographic Data Collection and Refinement Statistics 
 PfSir2A_myrH3K9 PfSir2A-myrH3K9-NAD 
Data collection   
Space group P21212 P21212 
Cell dimensions     
        a, b, c (Å) 32.51, 103.33, 105.51 32.17, 102.73, 105.18 
        α, β, γ  (°) 90, 90, 90 90, 90, 90 
Resolution (Å) 50-2.40 50-2.20 
Rsym or Rmerge (%) 14.9 (75.3) 12.9 (74.8) 
I / σI 23.83 (1.75) 24.7 (2.21) 
Completeness (%) 98.5 (97.2) 99.9 (99.9) 
Redundancy 8.2 (4.4) 6.7 (5.0) 
   
Refinement   
Resolution (Å) 50-2.40 50-2.20 
No. reflections 18972 23688 
Rwork / Rfree (%) 21.59 /27. 00 20.38/25.03 
No. of protein residues  263 271 
No. of  ligand/ion molecules   
        Myristoyl H3K9 1 1 
        NAD -- 1 
        Glycerol 1 1 
        Zn 1 1 
No. of water 26 78 
R.m.s deviations   
       Bond lengths (Å) 0.039 0.020 
       Bond angles (°) 2.18 1.93 
Numbers showed in the parentheses are for the highest resolution shell. 
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CONCLUDING REMARKS 
Our aim was to verify the importance of the two conserved residues in type III sirtuins 
and investigate the physiological significance of these new post translational modifications in a 
bacterial model. We investigated the activity of two sirtuins, E. coli CobB and P. falciparum 
Sir2A (PfSir2A). CobB contains the two active site residues, Tyr and Arg, that are conserved in 
most class III sirtuins, while PfSir2A does not have the Tyr and Arg residues even though it is 
classified as a class III sirtuin. We found that only CobB has desuccinylase activity while 
PfSir2A prefers to remove long fatty acyl chains. This finding further confirms the importance of 
the Tyr and Arg residues in recognizing negatively charged acyl groups, such as succinyl and 
malonyl. Interestingly, CobB is multifunctional sirtuin that can remove both acetyl and succinyl 
efficiently.  We also investigated CobB’s influence on metabolism in different nutrient 
conditions and found that desuccinylation was not important in acetate, succinate and propionate 
supplemented nutrients.   
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